Myricx Bio

Biotech & Life Sciences · London, United Kingdom · Founded 2019

Myricx Bio is a UK-based biotechnology company specializing in the discovery and development of a new class of selective cytotoxic payloads for antibody-drug conjugates (ADCs). These ADCs are based on inhibitors of the enzyme NMT (N-myristoyltransferase) and are designed to treat various types of cancer. The company operates in the biopharmaceutical market, targeting oncology therapeutics. Myricx Bio serves pharmaceutical companies and research institutions looking for advanced cancer treatment solutions. The business model revolves around research and development, followed by licensing agreements and partnerships with larger pharmaceutical firms to bring their innovations to market. Revenue is generated through these partnerships, licensing deals, and potentially future sales of developed therapies. Keywords: biotechnology, ADCs, NMT inhibitors, cancer treatment, oncology, cytotoxic payloads, drug development, licensing, partnerships, UK-based.

Valuation $100–500M

Headcount <100

Total funding $100–500M

Unlock exact values

Investors

7 investors on Myricx Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage

Brandon Capital Partners

Sofinnova Partners

Series A 5 investors entered at this stage

Abingworth

Novo Holdings

British Patient Capital

Eli Lilly

Cancer Research Horizon

Global footprint

Where Myricx Bio has talent and traffic

Workforce by country

4 countries with
team presence

🇬🇧 United Kingdom75%

🇺🇸 United States12.5%

🇩🇰 Denmark9.4%

🇨🇭 Switzerland3.1%

4 countries shown

Talent graph

The shape of Myricx Bio's talent

Dealroom maps Myricx Bio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

11 team members profilednamed & role-tagged by Dealroom

36 employeestotal headcount

6 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Myricx Bio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Myricx Bio

An AI-synthesized read of the highest-engagement posts about Myricx Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Myricx Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles